MBX Biosciences, Inc. Common Stock ( MBX) - Key Metrics
MBX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.78 | -$0.47 | -$0.49 |
| 2026Q1 | $0 | -$0.50 | -$0.43 | -$0.44 |
| 2025Q4 | $0 | -$0.60 | -$0.50 | -$0.52 |
| 2025Q3 | $0 | -$0.63 | -$0.63 | -$0.64 |
| 2025Q2 | $0 | -$0.58 | -$0.52 | -$0.54 |
MBX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -17.69 |
| 2026Q1 | 0% | -14.93 |
| 2025Q4 | 0% | -16.09 |
| 2025Q3 | 0% | -6.94 |
| 2025Q2 | 0% | -4.92 |
MBX
Price: $67.10
52 week price:
Earnings Per Share: 7.67 USD
P/E Ratio: 4.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.1 billion